Cumberland Pharmaceuticals (CPIX) Reports In-Line Q1 EPS, Revs Beat

May 14, 2019 4:11 PM

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q1 EPS of ($0.11), in-line with the analyst estimate of ($0.11). Revenue for the quarter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found